Ingredients & Formulation
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Ingredients & Formulation 159 stories
Ingredients & Formulation
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Watch for follow-on moves from competitors and reactions from key channel partners in the coming quarters.
Ingredients & Formulation
À l’occasion du congrès HLTH Europe 2026, le King Faisal Specialist Hospital présente son écosystème d’IA appliquée en radiologie
À l’occasion du congrès HLTH Europe 2026, le King Faisal Specialist Hospital présente son écosystème d’IA appliquée en …
Ingredients & Formulation
Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 sein Ökosystem für angewandte KI in der Radiologie
Ahmad AbuSalah, Direktor des Digital Innovation Hub am King Faisal Specialist Hospital & Research Centre (KFSH), stellt…
Ingredients & Formulation
King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026
Professor Ahmad AbuSalah, PhD, Director of the Digital Innovation Hub at King Faisal Specialist Hospital & Research Cen…
Ingredients & Formulation
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
Ingredients & Formulation
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
Ingredients & Formulation
Alvotech tilkynnir um verð og úthlutun hlutabréfa að andvirði um 152 milljónir dollara í útboði í Bandaríkjunum og lokuðu útboði til fagfjárfesta á Evrópska efnahagssvæðinu
júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) kynnti í dag ákvörðun um verð og úthlutun í áður boðuðu sölutryggðu hlut…
Ingredients & Formulation
Dignitas Wins NAIC: The ROOT Brands Powers Pokémon UNITE Victory
How Dignitas Pokémon UNITE utilized advanced cognitive support to dominate the NAIC and redefine wellness in esports.
Ingredients & Formulation
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differen…
Ingredients & Formulation
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO…
Ingredients & Formulation
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…